AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32314971 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat official account (Pulmonary Internet Explorer Rehabilitation [PeR])
Number of subjects: 106
Study 32314971 — intervention group
Group type: COMPARATOR
Intervention: Outpatient face‐to‐face group (FtF)
Number of subjects: 106
Study 35350970 — intervention group
Group type: EXPERIMENTAL
Intervention: START-Play physical therapy intervention
Number of subjects: 112
Study 33986149 — intervention group
Group type: EXPERIMENTAL
Intervention: Original scoring system
Number of subjects: 364
Study 33986149 — intervention group
Group type: EXPERIMENTAL
Intervention: New scoring system
Number of subjects: 364
Study 33986149 — intervention group
Group type: EXPERIMENTAL
Intervention: CART model
Number of subjects: 364
Study 33986149 — intervention group
Group type: EXPERIMENTAL
Intervention: Early neurologic clinical examination
Number of subjects: 364
Study 33986149 — intervention group
Group type: EXPERIMENTAL
Intervention: New CART model
Number of subjects: 364
Study 33986149 — intervention group
Group type: EXPERIMENTAL
Intervention: Early neurologic evaluation
Number of subjects: 364
Study 32379483 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity ultrasonically nebulized distilled water (UNDW) inhalations (1.6 ml/min)
Number of subjects: 24
Study 32379483 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity UNDW inhalations (0.5 ml/min)
Number of subjects: 24
Study 32379483 — intervention group
Group type: COMPARATOR
Intervention: Control, 0.9% saline inhalations (1.6 ml/min)
Number of subjects: 24
Study 35317941 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise programme (3h per week for 10 weeks)
Number of subjects: 76
Study 35317941 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Control Group)
Number of subjects: 76
Study 33245332 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy
Number of subjects: 80
Study 33245332 — intervention group
Group type: COMPARATOR
Intervention: Standard medical treatment (SMT)
Number of subjects: 80
Study 36200522 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program (24 weeks of aerobic and resistance exercise)
Number of subjects: 0
Study 36200522 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 36200522 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 0
Study 32792420 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised resistance training at home
Number of subjects: 15
Study 32792420 — intervention group
Group type: COMPARATOR
Intervention: Supervised resistance training in hospital
Number of subjects: 15
Study 32792420 — intervention group
Group type: COMPARATOR
Intervention: Standard care with information leaflet
Number of subjects: 15
Study 32519005 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (HS) - 5 ml/kg body weight of 7.3% NaCl over 60 min
Number of subjects: 101
Study 32519005 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS) - 0.9% NaCl over 60 min
Number of subjects: 101
Study 35290444 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutureless aortic valve replacement (Su‐AVR)
Number of subjects: 896
Study 35290444 — intervention group
Group type: COMPARATOR
Intervention: Stented sutured bioprosthesis (SAVR)
Number of subjects: 896
Study 33965268 — intervention group
Group type: EXPERIMENTAL
Intervention: Body dissatisfaction
Number of subjects: 811
Study 33965268 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction between body dissatisfaction and gender
Number of subjects: 811
Study 32423706 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticholinergics
Number of subjects: 154
Study 32423706 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (added if anticholinergics were not satisfactory)
Number of subjects: 154
Study 32423706 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant therapy (combined with desmopressin if needed)
Number of subjects: 154
Study 32423706 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment including desmopressin
Number of subjects: 154
Study 34378862 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gel 1% applied inside the implant hex
Number of subjects: 40
Study 34378862 — intervention group
Group type: COMPARATOR
Intervention: Control group (no gel applied)
Number of subjects: 40
Study 32059705 — intervention group
Group type: EXPERIMENTAL
Intervention: De-escalated primary radiotherapy (60 Gy) ± concomitant chemotherapy
Number of subjects: 140
Study 32059705 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral surgery (TOS) ± de-escalated adjuvant radiotherapy (50-60 Gy based on risk factors)
Number of subjects: 140
Study 35870710 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic radiotherapy (50Gy prescription dose)
Number of subjects: 132
Study 34401493 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible fiber carbon dioxide laser (Laser)
Number of subjects: 62
Study 34401493 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery (EC)
Number of subjects: 62
Study 32534807 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate with leucovorin rescue (HDMTX-LR)
Number of subjects: 0
Study 32534807 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33866849 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week training
Number of subjects: 62
Study 33866849 — intervention group
Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 62
Study 32126987 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct patient mailings and in-clinic referrals
Number of subjects: 1432
Study 36149216 — intervention group
Group type: COMPARATOR
Intervention: Standard Triple Therapy (sTT)
Number of subjects: 303
Study 36149216 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth-Containing Quadruple Therapy (BQT)
Number of subjects: 303
Study 36149216 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential Therapy (ST)
Number of subjects: 303
Study 36149216 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Therapy (HT)
Number of subjects: 303
Study 34922474 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial extreme gradient-boosting (XGBoost) model
Number of subjects: 0
Study 34922474 — intervention group
Group type: EXPERIMENTAL
Intervention: Final XGBoost model (after excluding hematological features)
Number of subjects: 0
Study 34161952 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-enhanced turmeric formulation (BTF) 1 g/day
Number of subjects: 60
Study 34161952 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-enhanced turmeric formulation (BTF) 1.5 g/day
Number of subjects: 60
Study 34161952 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34161952 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-enhanced turmeric formulation (BTF)
Number of subjects: 60
Study 32075611 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation coordinator intervention (RC)
Number of subjects: 0
Study 32075611 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 33271057 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG-driven exoneuromusculoskeleton with NMES and mechanical torque assistance
Number of subjects: 15
Study 33271057 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG-driven exoneuromusculoskeleton
Number of subjects: 15
Study 33271057 — intervention group
Group type: COMPARATOR
Intervention: No assistance provided
Number of subjects: 15
Study 32684633 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib-containing induction therapy (IT), high-dose melphalan (MEL200), autologous blood stem cell transplantation (ASCT), consolidation, and maintenance with lenalidomide
Number of subjects: 601
Study 35796614 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (750 mg)
Number of subjects: 32
Study 35796614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 32620337 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy food intake
Number of subjects: 104
Study 35381839 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg orally two hours before surgery and 24 hours after surgery
Number of subjects: 60
Study 35381839 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35381839 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 60
Study 35381839 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine and Placebo
Number of subjects: 60
Study 33626423 — intervention group
Group type: EXPERIMENTAL
Intervention: Henna application
Number of subjects: 56
Study 33626423 — intervention group
Group type: COMPARATOR
Intervention: Henna inert
Number of subjects: 56
Study 32275033 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper thoracic epidural analgesia (TEA)
Number of subjects: 60
Study 32275033 — intervention group
Group type: COMPARATOR
Intervention: Lower thoracic epidural analgesia (TEA)
Number of subjects: 60
Study 35768093 — intervention group
Group type: EXPERIMENTAL
Intervention: Tackle Your Tics (n=52)
Number of subjects: 104
Study 35768093 — intervention group
Group type: COMPARATOR
Intervention: Waiting list condition (n=52)
Number of subjects: 104
Study 34188908 — intervention group
Group type: EXPERIMENTAL
Intervention: Desarda repair
Number of subjects: 77
Study 34188908 — intervention group
Group type: COMPARATOR
Intervention: Lichtenstein repair
Number of subjects: 77
Study 36410128 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfort Marker 2.0® (CM)
Number of subjects: 100
Study 36410128 — intervention group
Group type: COMPARATOR
Intervention: Lancets
Number of subjects: 100
Study 34426987 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning algorithm for automated hair counting and length measurement
Number of subjects: 288
Study 33068344 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Guanyuan (CV 4) and Zusanli (ST 36) for 15 min
Number of subjects: 90
Study 33068344 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion at Guanyuan (CV 4) and Zusanli (ST 36) for 15 min
Number of subjects: 90
Study 33068344 — intervention group
Group type: COMPARATOR
Intervention: Blank group (no intervention)
Number of subjects: 90
Study 36420117 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg escitalopram
Number of subjects: 76
Study 36420117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 33210787 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-implantitis
Number of subjects: 99
Study 33210787 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-implant diseases
Number of subjects: 99
Study 33210787 — intervention group
Group type: EXPERIMENTAL
Intervention: PPD≥6 mm
Number of subjects: 99
Study 33210787 — intervention group
Group type: EXPERIMENTAL
Intervention: PPD≥8 mm
Number of subjects: 99
Study 33210787 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucosal dehiscence (MD)
Number of subjects: 99
Study 33210787 — intervention group
Group type: EXPERIMENTAL
Intervention: Total OHIP-14Sp sum score
Number of subjects: 99
Study 34268952 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab + DOS
Number of subjects: 106
Study 34268952 — intervention group
Group type: COMPARATOR
Intervention: DOS
Number of subjects: 106
Study 32282608 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon occlusion of the internal iliac arteries
Number of subjects: 100
Study 32282608 — intervention group
Group type: COMPARATOR
Intervention: Control group (no balloon occlusion)
Number of subjects: 100
Study 32282608 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon occlusion group
Number of subjects: 100
Study 32282608 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 34391265 — intervention group
Group type: EXPERIMENTAL
Intervention: KT activation (KTact)
Number of subjects: 37
Study 34391265 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham tape (KTst)
Number of subjects: 37
Study 34391265 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 37
Study 35979901 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-mL oral solution of aspirin (300 mg)
Number of subjects: 0
Study 35979901 — intervention group
Group type: COMPARATOR
Intervention: Chewed aspirin tablet (300 mg)
Number of subjects: 0
Study 33986063 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple
Number of subjects: 72
Study 33986063 — intervention group
Group type: EXPERIMENTAL
Intervention: Watermelon
Number of subjects: 72
Study 33986063 — intervention group
Group type: EXPERIMENTAL
Intervention: Cream cracker
Number of subjects: 72
Study 33986063 — intervention group
Group type: EXPERIMENTAL
Intervention: White bread
Number of subjects: 72
Study 36345961 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented reality (AR) app
Number of subjects: 23
Study 33210993 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea intake
Number of subjects: 3
Study 33210993 — intervention group
Group type: COMPARATOR
Intervention: Water intake
Number of subjects: 3
Study 33430928 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based delivery (HBD)
Number of subjects: 104
Study 33430928 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence clubs (AC)
Number of subjects: 104
Study 33430928 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SoC)
Number of subjects: 104
Study 32875582 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial treatment
Number of subjects: 0
Study 32875582 — intervention group
Group type: COMPARATOR
Intervention: Two-stage randomized trial design
Number of subjects: 0
Study 35815622 — intervention group
Group type: EXPERIMENTAL
Intervention: Competency-driven training (CDT)
Number of subjects: 24
Study 35815622 — intervention group
Group type: COMPARATOR
Intervention: Training-as-usual (TAU)
Number of subjects: 24
Study 33742282 — intervention group
Group type: EXPERIMENTAL
Intervention: HUGS intervention (4-session, group-based mother-infant interaction intervention)
Number of subjects: 77
Study 33742282 — intervention group
Group type: COMPARATOR
Intervention: Control playgroup (following cognitive-behavioral therapy for PND)
Number of subjects: 77
Study 32818720 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-body resiliency group intervention (8 sessions, in-person)
Number of subjects: 23
Study 32818720 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-body resiliency group intervention
Number of subjects: 23
Study 35017606 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral nostril breathing (UNB) using the non-dominant nasal airway
Number of subjects: 30
Study 35017606 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral nostril breathing (UNB) using the dominant nasal airway
Number of subjects: 30
Study 35017606 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral nostril breathing (UNB) using the left nostril
Number of subjects: 30
Study 35017606 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral nostril breathing (UNB) using the right nostril
Number of subjects: 30
Study 35017606 — intervention group
Group type: COMPARATOR
Intervention: Baseline (resting phase)
Number of subjects: 30
Study 34496907 — intervention group
Group type: EXPERIMENTAL
Intervention: External stenting of saphenous vein graft
Number of subjects: 0
Study 34496907 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional suggestion to external stenting
Number of subjects: 0
Study 34498822 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel iso-inertial resistance training (FW)
Number of subjects: 24
Study 34498822 — intervention group
Group type: COMPARATOR
Intervention: Traditional gravity-dependent resistance training (GD)
Number of subjects: 24
Study 33029843 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive diagnostic strategy (limited blood tests)
Number of subjects: 302
Study 33029843 — intervention group
Group type: COMPARATOR
Intervention: Strategy of exclusion (extensive blood tests, fecal samples for intestinal parasites, and sigmoidoscopy with biopsies)
Number of subjects: 302
Study 34773985 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein intake and early exercise (HPE)
Number of subjects: 181
Study 34773985 — intervention group
Group type: COMPARATOR
Intervention: Standard nutrition care and routine physiotherapy (Control)
Number of subjects: 181
Study 32776891 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled Differential Evolution (CDE) algorithm with Support Vector Machine (SVM) classification
Number of subjects: 205
Study 35898575 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 minutes of stair climbing and descending (SCD) at a self-selected comfortable pace
Number of subjects: 30
Study 35898575 — intervention group
Group type: COMPARATOR
Intervention: Seated control condition
Number of subjects: 30
Study 35170885 — intervention group
Group type: EXPERIMENTAL
Intervention: Prayer (reciting for 10 minutes three times daily)
Number of subjects: 120
Study 35170885 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger (250 mg capsules plus 20 ml water after each meal)
Number of subjects: 120
Study 35170885 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo starch capsules, 250 mg daily)
Number of subjects: 120
Study 35170885 — intervention group
Group type: EXPERIMENTAL
Intervention: Prayer
Number of subjects: 120
Study 35170885 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger
Number of subjects: 120
Study 35318971 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D Compressed-Sensing Fluid and White Matter Suppression (CS-FLAWS)
Number of subjects: 58
Study 35318971 — intervention group
Group type: COMPARATOR
Intervention: 2D T2-weighted imaging (reference)
Number of subjects: 58
Study 35318971 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D CS-FLAWS in patients who underwent sagittal T2 + short tau inversion recovery imaging
Number of subjects: 58
Study 35318971 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D CS-FLAWS
Number of subjects: 58
Study 33031520 — intervention group
Group type: EXPERIMENTAL
Intervention: Human amnion‐chorion membrane
Number of subjects: 43
Study 33031520 — intervention group
Group type: COMPARATOR
Intervention: Collagen membrane
Number of subjects: 43
Study 32366241 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal STI test selection
Number of subjects: 431
Study 34135189 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodized salt consumption (>15 ppm)
Number of subjects: 202
Study 34135189 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary iodine concentration (UIC)
Number of subjects: 202
Study 32697560 — intervention group
Group type: EXPERIMENTAL
Intervention: Photochromic contact lens
Number of subjects: 60
Study 32697560 — intervention group
Group type: COMPARATOR
Intervention: Nonphotochromic control
Number of subjects: 60
Study 34698704 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant Mental Health Home Visiting (IMH‐HV) treatment
Number of subjects: 62
Study 34698704 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 62
Study 33682353 — intervention group
Group type: EXPERIMENTAL
Intervention: Biologic therapy (a biologic disease-modifying antirheumatic drug plus methotrexate)
Number of subjects: 1502
Study 33682353 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy (methotrexate plus sulfasalazine plus hydroxychloroquine/chloroquine)
Number of subjects: 1502
Study 36037456 — intervention group
Group type: EXPERIMENTAL
Intervention: MI+st‐SES (sensory threshold somatosensory electrical stimulation) during MI tasks
Number of subjects: 30
Study 36037456 — intervention group
Group type: COMPARATOR
Intervention: Control group (performed MI tasks only)
Number of subjects: 30
Study 34440974 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual therapy (VR) in an eight-week cardiac rehabilitation program
Number of subjects: 43
Study 34440974 — intervention group
Group type: COMPARATOR
Intervention: Schultz's autogenic training (control group)
Number of subjects: 43
Study 35240087 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT plus pembrolizumab and trametinib
Number of subjects: 170
Study 35240087 — intervention group
Group type: COMPARATOR
Intervention: SBRT plus gemcitabine
Number of subjects: 170
Study 32545074 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived benefits
Number of subjects: 232
Study 32545074 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived barriers
Number of subjects: 232
Study 32545074 — intervention group
Group type: COMPARATOR
Intervention: Perceived threats
Number of subjects: 232
Study 35307850 — intervention group
Group type: EXPERIMENTAL
Intervention: P22-TAB (250 mg)
Number of subjects: 12
Study 35307850 — intervention group
Group type: EXPERIMENTAL
Intervention: P22-CAP (250 mg)
Number of subjects: 12
Study 35307850 — intervention group
Group type: COMPARATOR
Intervention: P01-CAP (250 mg)
Number of subjects: 12
Study 32311936 — intervention group
Group type: EXPERIMENTAL
Intervention: Perinatal individualized interventions based on self-efficacy theory
Number of subjects: 226
Study 32311936 — intervention group
Group type: COMPARATOR
Intervention: Usual care for lactation support
Number of subjects: 226
Study 34896294 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician education plus behavioral‐economics‐informed clinical decision support (CDS)
Number of subjects: 374
Study 34896294 — intervention group
Group type: COMPARATOR
Intervention: Clinician education alone
Number of subjects: 374
Study 34890377 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 days antibiotic therapy (SDR group)
Number of subjects: 113
Study 34890377 — intervention group
Group type: COMPARATOR
Intervention: 14 days antibiotic therapy (LDR group)
Number of subjects: 113
Study 35396075 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical noninvasive vagus nerve stimulation (nVNS) for two weeks
Number of subjects: 16
Study 35396075 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment for two weeks
Number of subjects: 16
Study 34925204 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) combined with conventional, individualised rehabilitation therapy.
Number of subjects: 40
Study 34925204 — intervention group
Group type: COMPARATOR
Intervention: Conventional, individualised rehabilitation therapy (Control group).
Number of subjects: 40
Study 36335393 — intervention group
Group type: EXPERIMENTAL
Intervention: Subacromial decompression (Group SAD)
Number of subjects: 69
Study 36335393 — intervention group
Group type: EXPERIMENTAL
Intervention: Debridement of calcifications (Group D)
Number of subjects: 69